文献速递妇产影像技术与安全US

妇科影像报告与数据系统(GI-RADS):诊断效能与阅片者间一致性

Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement.
PubMed 文献 · Eur Radiol · 2019-04-16

前瞻性多中心研究纳入308名女性共325个超声检出的附件肿块,按GI-RADS分类并以组织病理学和超声随访为参考标准计算诊断效能。仅以GR5预测恶性时敏感度92.9%、特异度97.5%、准确率95.7%;合并GR4与GR5时分别为97.6%、93.9%、95.4%,阅片者间一致性很好(κ=0.896)。

要点

  • GR2共95个肿块均无恶性,GR3共94个中3个恶性,GR5共123个中118个恶性。
  • 仅以GR5预测恶性时敏感度92.9%、特异度97.5%、准确率95.7%。
  • 合并GR4与GR5预测恶性时敏感度97.6%、特异度93.9%、准确率95.4%。

核心结论

  • GI-RADS对提高附件肿块超声结构化报告很有价值,其标准简便且效能至少与IOTA相当。

研究设计与样本

  • 前瞻性多中心研究,纳入308名女性(平均年龄41±12.5岁,范围15-73岁)的325个超声检出附件肿块,按GI-RADS五分类,以组织病理学和超声随访为参考标准,用Fleiss kappa评估阅片者间一致性。

诊断标准与关键数值

  • 基于病灶分析,仅以GR5预测恶性时GI-RADS敏感度92.9%、特异度97.5%、准确率95.7%;合并GR4与GR5预测恶性时敏感度97.6%、特异度93.9%、准确率95.4%。

临床应用与阅片要点

  • 325个附件肿块中127个(39.1%)恶性、198个(60.9%)良性;GR2共95个均无恶性,GR3共94个中3个恶性,GR4共13个中6个恶性,GR5共123个中118个恶性;GI-RADS分类阅片者间一致性很好(κ=0.896),预测恶性的最佳截断值为>GR3。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To evaluate diagnostic performance and inter-reviewer agreement (IRA) of the Gynecologic Imaging Reporting and Data System (GI-RADS) for diagnosis of adnexal masses (AMs) by pelvic ultrasound (US).

PATIENTS AND METHODS: A prospective multicenter study included 308 women (mean age, 41 ± 12.5 years; range, 15-73 years) with 325 AMs detected by US. All US examinations were analyzed, and AMs were categorized into five categories according to the GI-RADS classification. We used histopathology and US follow-up as the reference standards for calculating diagnostic performance of GI-RADS for detecting malignant AMs. The Fleiss kappa (κ) tests were applied to evaluate the IRA of GI-RADS scoring results for predicting malignant AMs.

RESULTS: A total of 325 AMs were evaluated: 127 (39.1%) were malignant and 198 (60.9%) were benign. Of 95 AMs categorized as GI-RADS 2 (GR2), none was malignant; of 94 AMs categorized as GR3, three were malignant; of 13 AMs categorized as GR4, six were malignant; and of 123 AMs categorized as GR5, 118 were malignant. On a lesion-based analysis, the GI-RADS had a sensitivity, a specificity, and an accuracy of 92.9%, 97.5%, and 95.7%, respectively, when regarding only those AMs classified as GR5 for predicting malignancy. Considering combined GR4 and GR5 as a predictor for malignancy, the sensitivity, specificity, and accuracy of GI-RADS were 97.6%, 93.9%, and 95.4%, respectively. The IRA of the GI-RADS category was very good (κ = 0.896). The best cutoff value for predicting malignant AMs was >GR3.

CONCLUSIONS: The GI-RADS is very valuable for improving US structural reports.

KEY POINTS: • There is still a lack of a standard in the assessment of AMs. • GI-RADS is very valuable for improving US structural reports of AMs. • GI-RADS criteria are easy and work at least as well as IOTA.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Basha MAA, Refaat R, Ibrahim SA, et al. Gynecology Imaging Reporting and Data System (GI-RADS): diagnostic performance and inter-reviewer agreement. Eur Radiol. 2019. PMID: 30993433. doi:10.1007/s00330-019-06181-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。